Riskpilot← Back to searchSign inGet full accessBENCHMARK GENETICS SALTEN AS
ASActiveOrg 916000030Sørfjordmoen Kobbelv, 8264 EnganMarine aquaculture · NACE 0321Est. 201539 employees
Revenue 2024
NOK 297,5M
+2% vs 2023
EBITDA margin
27.2%
-20% vs 2023
Equity ratio
37.4%
Financial strength
Net profit 2024
NOK 34,8M
-29% vs 2023
| Revenue | NOK 297,5M | +2% |
| EBITDA | NOK 81M | -20% |
| Net profit | NOK 34,8M | -29% |
| Total assets | NOK 801,7M | +11% |
| Equity | NOK 299,9M | +12% |
| Employees | 39 | — |
Legal name
BENCHMARK GENETICS SALTEN AS
Org number
916000030
Legal form
Aksjeselskap
NACE code
0321 · Marine aquaculture
Founded
29. september 2015
Share capital
NOK 25 030 000
Employees
39 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Tilrettelegge for etablering av et landbasert produksjonsanlegg for lakserogn.
Address
Sørfjordmoen Kobbelv, 8264 Engan
Phone
+4794164392
Email
salten@salmobreed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 466 | 29 754 | 105 149 | 171 717 | 206 758 | 292 670 | 297 528 |
| Staff expenses | −0 | −0 | −194 | −9 | −1 563 | −19 624 | −22 622 | −24 772 | −25 763 | −29 513 |
| EBITDA | −12 | −531 | −1 009 | −575 | 1 332 | 46 359 | 50 328 | 98 556 | 100 662 | 80 992 |
| Depreciation & amort. | −0 | −0 | −41 | −356 | −4 699 | −17 131 | −17 901 | −18 967 | −19 297 | −19 721 |
| EBIT | −12 | −531 | −1 050 | −931 | −3 367 | 29 228 | 32 427 | 79 589 | 81 366 | 61 271 |
| Net financials | 0 | −151 | 1 | 46 | −13 878 | −14 222 | −12 536 | −12 777 | −18 410 | −17 551 |
| Profit before tax | −12 | −683 | −1 049 | −885 | −17 245 | 15 006 | 19 891 | 66 812 | 62 956 | 43 720 |
| Tax | −0 | −0 | −0 | −0 | −0 | −2 517 | 5 750 | 16 106 | 14 236 | 8 926 |
| Net profit | −12 | −683 | −1 049 | −885 | −17 245 | 17 523 | 14 141 | 50 706 | 48 720 | 34 794 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 195 | 56 274 | 285 765 | 537 295 | 511 297 | 541 085 | 541 505 | 606 830 | 721 173 | 801 724 |
| Equity | 1 188 | 25 501 | 148 436 | 147 551 | 127 722 | 140 090 | 160 857 | 217 912 | 268 233 | 299 880 |
| Long-term debt | 0 | 0 | 11 626 | 344 650 | 348 989 | 324 177 | 299 778 | 275 629 | 290 424 | 243 908 |
| Short-term debt | 7 | 30 772 | 125 704 | 45 094 | 34 586 | 76 819 | 80 870 | 113 290 | 162 516 | 257 936 |
| Total debt | 7 | 30 772 | 137 329 | 389 744 | 383 575 | 400 995 | 380 648 | 388 918 | 452 940 | 501 843 |
EBITDA margin
27.2%
This company
15.8%
Market median
+72% vs market
20152024
Equity ratio
37.4%
This company
38.2%
Market median
+2% vs market
20152024
Return on equity
11.6%
This company
18.4%
Market median
+37% vs market
20152024
Net profit margin
11.7%
This company
8.1%
Market median
+44% vs market
20152024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20152024
Debt / equity
1.67×
This company
0.62×
Market median
-169% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-09-30
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
AS Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Benchmark Genetics Norway As | Company | 75.0% | 75.0% | 2024 |
Salten Stamfisk As | Company | 25.0% | 25.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Benchmark Genetics Norway As
BENCHMARK GENETICS SALTEN AS Board members of BENCHMARK GENETICS SALTEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Botnen | Chief Executive Officer | 0 companies |
| Ann-Kristin Skaugvold | Chief Executive Officer | 0 companies |
| Pablo Ignacio Mazo Traversi | Chairman | 0 companies |
| Jonathan Michael Crowther | Board of Directors | 0 companies |
| Jan-Emil Johannessen | Chairman | 0 companies |
| Geir Wenberg | Board of Directors | 0 companies |
| Jarle Solemdal | Board of Directors | 0 companies |
| Jonas Jonasson | Board of Directors | 0 companies |
| Geir Olav Melingen | Chairman | 0 companies |